Reviews expedited marketing approval, intellectual property, and innovation issues pertaining to follow-on biologics, also called biopharmaceutials or biotechnology drugs.
ProQuest U.S. Congressional Research Digital Collection
Note:
Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed Dec. 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. AVAILABLE ONLINE TO AUTHORIZED PSU USERS.